Status:
COMPLETED
Transurethral Focal Laser Ablation Versus Transurethral Prostatectomy For Management Of Benign Prostatic Obstruction
Lead Sponsor:
Ain Shams University
Conditions:
Benign Prostate Hypertrophy(BPH)
Eligibility:
MALE
Phase:
NA
Brief Summary
Introduction and objectives: Laser prostatectomy has become an increasingly popular and effective alternative to transurethral resection of the prostate (TURP) for the treatment of benign prostatic hy...
Detailed Description
INTRODUCTION Benign prostatic hyperplasia is a frequent condition between aging men, often leading to lower urinary tract symptoms (LUTS) that significantly impair quality of life. TURP was long consi...
Eligibility Criteria
Inclusion
- Patients with lower urinary tract symptoms (voiding ± storage) refractory to medical treatment with IPSS \> 20 (International Prostate Symptom Score) and Qmax \< 15 mL/sec
- Refractory acute urinary retention
- Hematuria or recurrent urinary tract infections secondary to BPH
- Renal impairment secondary to prostatic obstruction
Exclusion
- Proven malignancy by biopsy
- Urethral strictures
- Urinary bladder stones
- Previous prostate surgery
- Urodynamically proven neurogenic bladder
- Bladder cancer
- Unfit for anesthesia
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT07196475
Start Date
June 1 2021
End Date
June 1 2023
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain shams university _faculty of medicine
Cairo, Egypt